EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?

Lisa Götz, Uwe Rueckschloss, Sonia M Najjar, Süleyman Ergün, Florian Kleefeldt iD

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14337 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Lisa Götz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy and Cell Biology, University of Wuerzburg, Wuerzburg, Germany. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Neoplasms, Antigens, CD, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Open Access Publication Fund of the University of Würzburg, Cancer Research Advancement Foundation, Walter Schulz Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1, also CD66a), a transmembrane glycoprotein of the immunoglobulin superfamily, is a pivotal mediator of various physiological and pathological processes, including oncologic disorders. However, its precise role in tumorigenicity is contradictory discussed by several clinical studies. This review aims to elucidate the clinical significance of CEACAM1 in different cancer entities focusing on tumour formation, progression and metastasis as well as on CEACAM1‐mediated treatment resistance. Furthermore, we discuss the contribution of CEACAM1 to cancer immunity and modulation of the inflammatory microenvironment and finally provide a comprehensive review of treatment regimens targeting this molecule.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion MoleculesNeoplasmsAntigens, CDTumor MicroenvironmentHumansDrug Resistance, NeoplasmDisease ProgressionNeoplasm MetastasisCEACAM1 Protein

Stichwörter der Autor:innen

CD66aCEACAM1cancerinflammationtumorigenicitytumour microenvironment

Substanzen

CD66 antigensCell Adhesion MoleculesAntigens, CDCEACAM1 Protein

Autor:innen und Institutionen

  • Institute of Anatomy and Cell Biology, University of Wuerzburg, Wuerzburg, Germany.
  • Department of Biomedical Sciences, Heritage College of Osteopathic Medicine Irvine Hall, Ohio University, Athens, Ohio, USA.

ORCID-Profile: Florian Kleefeldt

Förderung

  • Open Access Publication Fund of the University of Würzburg
  • Cancer Research Advancement Foundation
  • Walter Schulz Foundation

Zitieren

APA

Götz, L., Rueckschloss, U., Najjar, S. M., Ergün, S., & Kleefeldt, F. (2024). Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14337

Vancouver

Götz L, Rueckschloss U, Najjar SM, Ergün S, Kleefeldt F. Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14337

BibTeX
@article{Gtz2024,
  author = {Götz, Lisa and Rueckschloss, Uwe and Najjar, Sonia M and Ergün, Süleyman and Kleefeldt, Florian},
  title = {Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14337}
}
Kostenlos starten →